MCID: BRN028
MIFTS: 70

Brain Cancer malady

Categories: Rare diseases, Cancer diseases, Neuronal diseases

Aliases & Classifications for Brain Cancer

Aliases & Descriptions for Brain Cancer:

Name: Brain Cancer 12 52 14
Adult Brain Tumor 12 52 69
Primary Malignant Neoplasm of Brain 12 69
Neoplasm of Brain 12 29
Brain Neoplasms 42 69
Brain Tumors 52 41
Neoplasm of Unspecified Nature of Brain 12
Malignant Primary Brain Neoplasm 12
Adult Malignant Brain Neoplasm 12
Malignant Tumor of Adult Brain 12
Malignant Primary Brain Tumors 52
Malignant Primary Brain Tumor 12
Malignant Neoplasm of Brain 69
Malignant Tumor of Brain 12
Malignant Brain Tumour 12
Primary Brain Neoplasm 12
Brain Neoplasm, Adult 12
Brain Tumor, Primary 69
Primary Brain Tumor 12
Brain Tumor Primary 52
Tumor of the Brain 12
Brain Tumor, Adult 50
Bt - Brain Tumour 12
Brain Neoplasm 12

Classifications:



Summaries for Brain Cancer

MedlinePlus : 41 a brain tumor is a growth of abnormal cells in the tissues of the brain. brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. some are primary brain tumors, which start in the brain. others are metastatic, and they start somewhere else in the body and move to the brain. brain tumors can cause many symptoms. some of the most common are headaches, often in the morning nausea and vomiting changes in your ability to talk, hear, or see problems with balance or walking problems with thinking or memory feeling weak or sleepy changes in your mood or behavior seizures doctors diagnose brain tumors by doing a neurologic exam and tests including an mri, ct scan, and biopsy. treatment options include watchful waiting, surgery, radiation therapy, chemotherapy, and targeted therapy. targeted therapy uses substances that attack cancer cells without harming normal cells. many people get a combination of treatments. nih: national cancer institute

MalaCards based summary : Brain Cancer, also known as adult brain tumor, is related to traumatic brain injury and brain tumor, childhood, and has symptoms including back pain, headache and pain. An important gene associated with Brain Cancer is EGFR (Epidermal Growth Factor Receptor), and among its related pathways/superpathways are Development HGF signaling pathway and MicroRNAs in cancer. The drugs Gliadel Wafer and Temodar have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and lung, and related phenotypes are Increased cell death HMECs cells and cellular

Disease Ontology : 12 A central nervous system cancer that is characterized by the growth of abnormal cells in the tissues of the brain.

Wikipedia : 71 A brain tumor or intracranial neoplasm occurs when abnormal cells form within the brain. There are two... more...

Related Diseases for Brain Cancer

Diseases related to Brain Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 157)
id Related Disease Score Top Affiliating Genes
1 traumatic brain injury 29.4 BMI1 CTNNB1 TP53
2 brain tumor, childhood 12.0
3 epidermoid brain tumor 12.0
4 prostate cancer/brain cancer susceptibility, somatic 11.8
5 childhood germ cell brain tumor 11.8
6 brain stem cancer 11.2
7 spinal cancer 10.6
8 glioma susceptibility 1 10.6
9 pilocytic astrocytoma 10.6
10 brain and spinal tumors 10.6
11 mismatch repair cancer syndrome 10.5
12 brain glioma 10.5
13 supratentorial cancer 10.5
14 atypical teratoid rhabdoid tumor 10.5
15 infratentorial cancer 10.5
16 exertional headache 10.4 ABCG2 BMI1
17 endometrial squamous cell carcinoma 10.3 AKT1 MGMT TP53
18 wolffian adnexal neoplasm 10.3 EGFR TP53
19 thrombophlebitis 10.3 ENO2 GFAP SMARCB1
20 breast ductal carcinoma 10.3 CTNNB1 PTEN TP53
21 myxedema 10.3 EGFR PTEN TP53
22 spastic paraplegia 1 10.3 ABCB1 EGFR TP53
23 lower lip cancer 10.3 AKT1 EGFR PTEN
24 reactive arthritis 10.3 CTNNB1 EGFR TP53
25 multicentric papillary thyroid carcinoma 10.3 CTNNB1 EGFR TP53
26 liver fibrosarcoma 10.3 GFAP TP53
27 brachial plexus neuropathy 10.3 EGFR ENO2 TP53
28 sengers syndrome 10.3 EGFR GFAP PTEN
29 temporal lobe neoplasm 10.3 CTNNB1 GFAP SMARCB1
30 heavy chain disease 10.3 CTNNB1 ENO2 GFAP
31 connective tissue benign neoplasm 10.3 AKT1 EGFR TP53
32 adult medulloblastoma 10.3 AKT1 EGFR PTEN TP53
33 fibromatosis, gingival, 1 10.3 CTNNB1 MYCN PTEN
34 thyrotoxic periodic paralysis 2 10.3 CTNNB1 PTCH1 PTEN
35 ophn1 syndrome 10.3 GFAP MGMT
36 prostatic adenoma 10.3 CTNNB1 EGFR PTEN TP53
37 paternal uniparental disomy of chromosome 1 10.3 EGFR GFAP TP53
38 cervical adenoid cystic carcinoma 10.3 GFAP TP53
39 paroxysmal nocturnal hemoglobinuria 10.3 AKT1 CTNNB1 EGFR TP53
40 dental caries 10.3 AKT1 EGFR TP53
41 nasal cavity disease 10.3 AKT1 EGFR TP53
42 blood group incompatibility 10.3 ENO2 GFAP TP53
43 mast-cell sarcoma 10.3 GFAP SMARCB1 TP53
44 olfactory neuroblastoma 10.3 GFAP SMARCB1 TP53
45 pearson syndrome 10.3 AKT1 CTNNB1 EGFR TP53
46 amyloid tumor 10.3 GFAP MGMT TP53
47 endocrine organ benign neoplasm 10.3 CTNNB1 ENO2 SMARCB1 TP53
48 adult syndrome 10.3 CTNNB1 PTEN TP53 TP73
49 ovarian mucinous adenocarcinoma 10.3 ABCB1 ABCG2 AKT1 GFAP
50 facial dermatosis 10.2 CTNNB1 EGFR MGMT TP53

Comorbidity relations with Brain Cancer via Phenotypic Disease Network (PDN):


Acute Cystitis Brain Edema
Epilepsy, Focal, with Speech Disorder and with or Without Mental Retardation Hypertension, Essential
Obstructive Hydrocephalus Schizophreniform Disorder

Graphical network of the top 20 diseases related to Brain Cancer:



Diseases related to Brain Cancer

Symptoms & Phenotypes for Brain Cancer

UMLS symptoms related to Brain Cancer:


back pain, headache, pain, sciatica, seizures, syncope, tremor, chronic pain, vertigo/dizziness, sleeplessness

GenomeRNAi Phenotypes related to Brain Cancer according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased cell death HMECs cells GR00103-A-0 9.1 BMI1 CTNNB1 EGFR PTEN TFRC TP53

MGI Mouse Phenotypes related to Brain Cancer:

44 (show all 28)
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.53 ABCG2 AKT1 BIRC6 CTNNB1 DMBT1 EGFR
2 homeostasis/metabolism MP:0005376 10.51 EGFR GFAP GLI3 MGMT MYCN PTCH1
3 cardiovascular system MP:0005385 10.48 ABCB1 AKT1 BIRC6 CTNNB1 EGFR GFAP
4 growth/size/body region MP:0005378 10.47 TP53 TP73 EGFR ENO2 GFAP GLI3
5 mortality/aging MP:0010768 10.45 ABCB1 AKT1 BIRC6 CTNNB1 DMBT1 EGFR
6 digestive/alimentary MP:0005381 10.43 PTEN SMARCB1 TFRC TP53 TP73 ABCB1
7 embryo MP:0005380 10.42 PTCH1 PTEN SMARCB1 TFRC TP53 TP73
8 immune system MP:0005387 10.41 ABCB1 ABCG2 AKT1 BIRC6 CTNNB1 DMBT1
9 hematopoietic system MP:0005397 10.4 ABCB1 ABCG2 AKT1 BIRC6 CTNNB1 EGFR
10 behavior/neurological MP:0005386 10.38 ABCB1 AKT1 CTNNB1 ENO2 GFAP MYCN
11 nervous system MP:0003631 10.38 ABCB1 ABCG2 AKT1 BIRC6 CTNNB1 EGFR
12 endocrine/exocrine gland MP:0005379 10.35 ABCB1 AKT1 BIRC6 CTNNB1 EGFR GLI3
13 liver/biliary system MP:0005370 10.28 CTNNB1 EGFR MYCN PTEN SMARCB1 TFRC
14 integument MP:0010771 10.26 ABCG2 AKT1 BIRC6 CTNNB1 EGFR GLI3
15 craniofacial MP:0005382 10.22 CTNNB1 EGFR ENO2 GLI3 MYCN PTCH1
16 normal MP:0002873 10.21 TP53 ABCG2 AKT1 BIRC6 CTNNB1 EGFR
17 neoplasm MP:0002006 10.19 MGMT PTCH1 PTEN SMARCB1 TP53 TP73
18 muscle MP:0005369 10.16 AKT1 CTNNB1 EGFR GFAP MYCN PTCH1
19 no phenotypic analysis MP:0003012 10.16 ABCB1 ABCG2 CTNNB1 EGFR GLI3 MGMT
20 hearing/vestibular/ear MP:0005377 10.14 ABCB1 CTNNB1 DMBT1 EGFR GLI3 TP53
21 limbs/digits/tail MP:0005371 10.09 CTNNB1 EGFR GLI3 MYCN PTCH1 PTEN
22 reproductive system MP:0005389 10.06 GLI3 MYCN PTCH1 PTEN SMARCB1 TP53
23 renal/urinary system MP:0005367 10.02 ABCG2 CTNNB1 DMBT1 EGFR GLI3 MYCN
24 respiratory system MP:0005388 10 AKT1 CTNNB1 EGFR ENO2 GLI3 MGMT
25 pigmentation MP:0001186 9.88 CTNNB1 EGFR GLI3 PTCH1 PTEN TP53
26 skeleton MP:0005390 9.81 AKT1 CTNNB1 EGFR GLI3 MYCN PTCH1
27 vision/eye MP:0005391 9.32 CTNNB1 EGFR GFAP GLI3 MYCN PTCH1
28 taste/olfaction MP:0005394 9.26 CTNNB1 ENO2 GLI3 PTEN

Drugs & Therapeutics for Brain Cancer

FDA approved drugs:

id Drug Name Active Ingredient(s) 17 Company Approval Date
1
Gliadel Wafer 17 46 CARMUSTINE Rhone-Poulenc Rorer, Guilford Pharmaceuticals Approved February 1997
2
Temodar 17 46 TEMOZOLOMIDE Schering-Plough Approved August 1999
3
Alecensa 17 ALECTINIB HYDROCHLORIDE Roche Approved December 2015

Drugs for Brain Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1004)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1 64-17-5 702
2
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-61-6, 62-31-7 681
3
Mannitol Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 69-65-8 453 6251
4
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
5
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
6
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 147-94-4 6253
7
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1959-05-2, 59-05-2 126941
8
Carboplatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 41575-94-4 10339178 498142 38904
9
Midazolam Approved, Illicit Phase 4,Phase 2 59467-70-8 4192
10
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 2 73590-58-6 4594
11
Celecoxib Approved, Investigational Phase 4,Phase 2 169590-42-5 2662
12
Memantine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 19982-08-2 4054
13
Octreotide Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 83150-76-9 383414 6400441
14
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-23-7 5754 657311
15
Infliximab Approved Phase 4,Phase 3,Phase 2 170277-31-3
16
Cabergoline Approved Phase 4,Phase 2,Phase 3 81409-90-7 54746
17
Dexmedetomidine Approved, Vet_approved Phase 4,Phase 3 76631-46-4, 113775-47-6 68602 5311068 56032
18
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1 3778-73-2 3690
19
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-24-8 5755
20
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
21
Mechlorethamine Approved Phase 4,Phase 3,Phase 1,Phase 2 51-75-2 4033
22
Dacarbazine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 4342-03-4 5351166
23
Temozolomide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 85622-93-1 5394
24
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 2078-54-8 4943
25
Menthol Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 2216-51-5 16666
26
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 437-38-7 3345
27
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 83-43-2 6741
28
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2 53-03-2 5865
29
Norepinephrine Approved Phase 4,Phase 3 51-41-2 439260
30
Gabapentin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 60142-96-3 3446
31
Lamotrigine Approved, Investigational Phase 4,Phase 1,Phase 2 84057-84-1 3878
32
Nicotine Approved Phase 4,Phase 3,Phase 2 54-11-5 942 89594
33
Pioglitazone Approved, Investigational Phase 4,Phase 1 111025-46-8 4829
34
Zinc Approved Phase 4,Phase 1,Early Phase 1 7440-66-6 32051 23994
35
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 57-83-0 5994
36
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-78-2 2244
37
Mitoxantrone Approved, Investigational Phase 4 65271-80-9 4212
38
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2 57-27-2 5288826
39
Acetaminophen Approved Phase 4,Phase 2 103-90-2 1983
40
Ibuprofen Approved Phase 4,Phase 3 15687-27-1 3672
41
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1 657-24-9 14219 4091
42
Valproic Acid Approved, Investigational Phase 4,Phase 2,Phase 1 99-66-1 3121
43
Hydralazine Approved Phase 4 86-54-4 3637
44
Donepezil Approved Phase 4,Phase 3,Phase 2,Phase 1 120014-06-4 3152
45
Acetylcholine Approved Phase 4,Phase 1,Phase 2 51-84-3 187
46 Piracetam Approved Phase 4,Phase 2 7491-74-9
47
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
48
Allopurinol Approved Phase 4,Phase 2 315-30-0 2094
49
Topiramate Approved Phase 4,Phase 1,Phase 2 97240-79-4 5284627
50
Phenylephrine Approved Phase 4 59-42-7 6041

Interventional clinical trials:

(show top 50) (show all 3339)
id Name Status NCT ID Phase
1 Characterization of Receptors in Non-functioning Pituitary Macroadenomas Unknown status NCT00852501 Phase 4
2 Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions Unknown status NCT02190994 Phase 4
3 Comparison of 20% Mannitol and 3% Hypertonic Saline for Cerebral Relaxation During Elective Supratentorial Craniotomies Unknown status NCT01745081 Phase 4
4 Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy Unknown status NCT00454935 Phase 4
5 Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion Unknown status NCT00313066 Phase 4
6 Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in Polycystic Ovary Syndrome (PCOS) Patients Unknown status NCT01246310 Phase 4
7 Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery Completed NCT00571155 Phase 4
8 Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors Completed NCT02034708 Phase 4
9 Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors Completed NCT00075166 Phase 4
10 A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients Completed NCT00952081 Phase 4
11 Multihance at 3 Tesla in Brain Tumors Completed NCT00395863 Phase 4
12 Learning Impairments Among Survivors of Childhood Cancer Completed NCT00576472 Phase 4
13 Phase IV Bioseal Study in Brain Tumor Surgery Completed NCT02034799 Phase 4
14 Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System Completed NCT02343081 Phase 4
15 Scalp Nerve Block and Opioid Consumption in Brain Surgery Completed NCT02057367 Phase 4
16 Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy Completed NCT02810899 Phase 4
17 The Use of Fentanyl in General Anesthesia for Craniotomy With or Without 0.5% Levobupivacaine Scalp Block Completed NCT02558569 Phase 4
18 Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants Completed NCT02708056 Phase 4
19 Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation Completed NCT00336531 Phase 4
20 Crossover Comparison of MultiHance and Dotarem Completed NCT02070380 Phase 4
21 Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain Completed NCT01613417 Phase 4
22 A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain Completed NCT00323102 Phase 4
23 A Pilot Study of Pre- and Post-operative Use of Somatuline Depot. Completed NCT01861717 Phase 4
24 Validation of 3 Dimensional Laparoscopic System in Disral Pancreatectomy and Splenectomy Completed NCT02757690 Phase 4
25 Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly Completed NCT00376064 Phase 4
26 Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy Completed NCT02593942 Phase 4
27 Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors Completed NCT02351700 Phase 4
28 Effect of 5 Years of GH Replacement on Atherosclerosis Completed NCT00462475 Phase 4
29 Surgical Debulking of Pituitary Adenomas Completed NCT01371643 Phase 4
30 Sleep Quality After Stellate-ganglion Block of Patients Undergoing Breast Cancer Operation Completed NCT02651519 Phase 4
31 DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor Completed NCT00029523 Phase 4
32 Herb-Opioid Interactions Completed NCT00027014 Phase 4
33 Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL) Completed NCT00153530 Phase 4
34 A Comparison of the Face Mask and Oral Mask Ventilation After Nasal Surgery Completed NCT01869673 Phase 4
35 An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue Completed NCT00678691 Phase 4
36 Myobloc Atrophy Study Completed NCT02052024 Phase 4
37 Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly Completed NCT00627796 Phase 4
38 A Study of the Neurobiology of Depression Completed NCT01051466 Phase 4
39 Pathophysiology of Post Amputation Pain Completed NCT01632709 Phase 4
40 Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly Completed NCT00461149 Phase 4
41 Octreotide Efficacy and Safety in First-line Acromegalic Patients Completed NCT00171886 Phase 4
42 A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease) Completed NCT00304291 Phase 4
43 A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency Completed NCT00455884 Phase 4
44 Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients Completed NCT00642720 Phase 4
45 Cardiac Valve Complications in Prolactinomas Treated With Cabergoline Completed NCT00460616 Phase 4
46 Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis Completed NCT00179478 Phase 4
47 Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation Completed NCT00360074 Phase 4
48 Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease Completed NCT00364858 Phase 4
49 A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease Completed NCT00081497 Phase 4
50 A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease Completed NCT00074984 Phase 4

Search NIH Clinical Center for Brain Cancer

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: brain neoplasms

Genetic Tests for Brain Cancer

Genetic tests related to Brain Cancer:

id Genetic test Affiliating Genes
1 Neoplasm of Brain 29

Anatomical Context for Brain Cancer

MalaCards organs/tissues related to Brain Cancer:

39
Brain, Testes, Lung, Breast, Liver, Endothelial, Prostate

Publications for Brain Cancer

Articles related to Brain Cancer:

(show top 50) (show all 488)
id Title Authors Year
1
Corrigendum to "Inferring the 1985-2014 impact of mobile phone use on selected brain cancer subtypes using Bayesian structural time series and synthetic controls" [Environ. Int. (2016), 97, 100-107]. ( 28131518 )
2017
2
British-led research uncovers new details on brain cancer. ( 28421936 )
2017
3
Toxicity of Cisplatin-Loaded Poly Butyl Cyanoacrylate Nanoparticles in a Brain Cancer Cell Line: Anionic Polymerization Results ( 28440967 )
2017
4
Utility of neurological smears for intrasurgical brain cancer diagnostics and tumour cell percentage by DESI-MS. ( 28112301 )
2017
5
Evaluation of [(18)F]-ATRi as PET tracer for in vivo imaging of ATR in mouse models of brain cancer. ( 28157626 )
2017
6
Time-A and oxygen-dependent expression and regulation of NDRG1 in human brain cancer cells. ( 28498432 )
2017
7
A mathematical theory of shape and neuro-fuzzy methodology-based diagnostic analysis: a comparative study on early detection and treatment planning of brain cancer. ( 28321787 )
2017
8
Non-invasive Photodynamic Therapy in Brain Cancer by Use of Tb(3+)-Doped LaF3 Nanoparticles in Combination with Photosensitizer Through X-ray Irradiation: A Proof-of-Concept Study. ( 28110445 )
2017
9
Radiomic Phenotyping in Brain Cancer to Unravel Hidden Information in Medical Images. ( 28079714 )
2017
10
Robust and fast characterization of OCT-based optical attenuation using a novel frequency-domain algorithm for brain cancer detection. ( 28327613 )
2017
11
The roles of microglia/macrophages in tumor progression of brain cancer and metastatic disease. ( 28410147 )
2017
12
Brain cancer therapy. ( 28104878 )
2017
13
Nasal HPpSIS administration enhances NGF and tumor suppressor protein, p73 in human brain cancer tissues: preliminary data. ( 28239803 )
2017
14
Using Epigenetic Reprogramming to Treat Pediatric Brain Cancer. ( 28486100 )
2017
15
Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. ( 28358926 )
2017
16
TPGS-chitosan cross-linked targeted nanoparticles for effective brain cancer therapy. ( 28254282 )
2017
17
QuickStats: Brain Cancer Death Rates Among Children and Teens Aged 1-19 Years,* by Sex(a8 ) and Age Group - United States, 2013-2015. ( 28472022 )
2017
18
Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization. ( 28263967 )
2017
19
Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications. ( 28374184 )
2017
20
Investigational new drugs for brain cancer. ( 27170161 )
2016
21
Brain cancer risk: the weight of obesity. ( 27830478 )
2016
22
Development of a bi-functional aptamer targeting the transferrin receptor and EpCAM for the treatment of brain cancer metastases. ( 28010059 )
2016
23
Brain cancer: Chemoradiotherapy for low-grade glioma: battle won, but the war goes on. ( 27092955 )
2016
24
Engineering a Brain Cancer Chip for High-throughput Drug Screening. ( 27151082 )
2016
25
OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells. ( 27585657 )
2016
26
Correction: Exploring the Support Needs of Family Caregivers of Patients with Brain Cancer Using the CSNAT: A Comparative Study with Other Cancer Groups. ( 26799832 )
2016
27
Does Lack of Resources within the Family Starting Point to Social Exclusion for Persons with Brain Cancer? ( 28163528 )
2016
28
SU-G-JeP2-08: Image-Guided Radiation Therapy Using Synthetic CTs in Brain Cancer. ( 28048467 )
2016
29
Proton beam therapy is as effective as radiotherapy in childhood brain cancer but less toxic, study shows. ( 26831911 )
2016
30
Neural networks improve brain cancer detection with Raman spectroscopy in the presence of operating room light artifacts. ( 27604560 )
2016
31
Pre-Adult MRI of Brain Cancer and Neurological Injury: Multivariate Analyses. ( 27446888 )
2016
32
Statins are Associated With a Reduced Risk of Brain Cancer: A Population-Based Case-Control Study. ( 27124024 )
2016
33
Accuracy of UTE-MRI-based patient setup for brain cancer radiation therapy. ( 26745919 )
2016
34
HILIC and ERLIC Enrichment of Glycopeptides Derived from Breast and Brain Cancer Cells. ( 27533485 )
2016
35
Immunotherapy of Brain Cancer. ( 27260656 )
2016
36
Automatic quality control in clinical (1) H MRSI of brain cancer. ( 27071355 )
2016
37
Intraoperative brain cancer detection with Raman spectroscopy in humans. ( 27004215 )
2016
38
Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells. ( 27834116 )
2016
39
Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy. ( 26701338 )
2016
40
Neurobehavioral radiation mitigation to standard brain cancer therapy regimens by Mn(III) n-butoxyethylpyridylporphyrin-based redox modifier. ( 27224425 )
2016
41
Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels - A Strategy for Brain Cancer Treatments. ( 26903051 )
2016
42
Inferring the 1985-2014 impact of mobile phone use on selected brain cancer subtypes using Bayesian structural time series and synthetic controls. ( 27835750 )
2016
43
Has the incidence of brain cancer risen in Australia since the introduction of mobile phones 29 years ago? ( 27551770 )
2016
44
Molecular mechanisms of OLIG2 transcription factor in brain cancer. ( 27447975 )
2016
45
I'm Still Me: Inspiration and Instruction from Individuals with Brain Cancer. ( 27398684 )
2016
46
Investigation of the expression of RIF1 gene on head and neck, pancreatic and brain cancer and cancer stem cells. ( 27917791 )
2016
47
Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR Images. ( 27398030 )
2016
48
Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer. ( 27882487 )
2016
49
Posttranslational Regulation of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and New Opportunities for Treatment of Brain Cancers. ( 26202203 )
2016
50
The use and impact of quality of life assessment tools in clinical care settings for cancer patients, with a particular emphasis on brain cancer: insights from a systematic review and stakeholder consultations. ( 27039304 )
2016